Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_assertion type Assertion NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_head.
- NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_assertion wasGeneratedBy ECO_0000203 NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_provenance.
- NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_assertion wasDerivedFrom befree-20150227 NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_provenance.
- NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_assertion SIO_000772 20616797 NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_provenance.
- NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_assertion evidence source_evidence_literature NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_provenance.
- NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_assertion description "[Expression levels in human myeloid leukemia directly correlate with decreased survival in patients with the disease, thereby defining MSI2 expression as a new prognostic marker and as a new target for therapy in acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968255.RAWrY0ppPuk1sr8U-5992a4zerRzSw0XH8O_WAke4k880130_provenance.